21 research outputs found
Genetic Influences on Patient-Oriented Outcomes in Traumatic Brain Injury: A Living Systematic Review of Non-Apolipoprotein E Single-Nucleotide Polymorphisms
There is a growing literature on the impact of genetic variation on outcome in traumatic brain injury (TBI). Whereas a
substantial proportion of these publications have focused on the apolipoprotein E (APOE) gene, several have explored the
influence of other polymorphisms.We undertook a systematic review of the impact of single-nucleotide polymorphisms (SNPs)
in non–apolipoprotein E (non-APOE) genes associated with patient outcomes in adult TBI). We searched EMBASE, MEDLINE, CINAHL, and gray literature from inception to the beginning of August 2017 for studies of genetic variance in relation to
patient outcomes in adult TBI. Sixty-eight articles were deemed eligible for inclusion into the systematic review. The SNPs
described were in the following categories: neurotransmitter (NT) in 23, cytokine in nine, brain-derived neurotrophic factor
(BDNF) in 12, mitochondrial genes in three, and miscellaneous SNPs in 21. All studies were based on small patient cohorts
and suffered from potential bias. A range of SNPs associated with genes coding for monoamine NTs, BDNF, cytokines, and
mitochondrial proteins have been reported to be associated with variation in global, neuropsychiatric, and behavioral outcomes.
An analysis of the tissue, cellular, and subcellular location of the genes that harbored the SNPs studied showed that they could be
clustered into blood–brain barrier associated, neuroprotective/regulatory, and neuropsychiatric/degenerative groups. Several
small studies report that various NT, cytokine, and BDNF-related SNPs are associated with variations in global outcome at 6–12
months post-TBI. The association of these SNPs with neuropsychiatric and behavioral outcomes is less clear. A definitiv
Restoring brain function after stroke - bridging the gap between animals and humans
Stroke is the leading cause of complex adult disability in the world. Recovery from stroke is often incomplete, which leaves many people dependent on others for their care. The improvement of long-term outcomes should, therefore, be a clinical and research priority. As a result of advances in our understanding of the biological mechanisms involved in recovery and repair after stroke, therapeutic opportunities to promote recovery through manipulation of poststroke plasticity have never been greater. This work has almost exclusively been carried out in preclinical animal models of stroke with little translation into human studies. The challenge ahead is to develop a mechanistic understanding of recovery from stroke in humans. Advances in neuroimaging techniques now enable us to reconcile behavioural accounts of recovery with molecular and cellular changes. Consequently, clinical trials can be designed in a stratified manner that takes into account when an intervention should be delivered and who is most likely to benefit. This approach is expected to lead to a substantial change in how restorative therapeutic strategies are delivered in patients after stroke
Recommended from our members
Remarks on Andrew Lang's World Trade Law After Neo-Liberalism
No abstract available
The indoor environmental quality in a Dutch day care cetres : the effects of ventilation on the conditions within the baby cots
Genetic drivers of cerebral blood flow dysfunction in TBI: a speculative synthesis
Cerebral autoregulatory dysfunction after traumatic brain injury (TBI) is strongly linked to poor global outcome in patients at 6 months after injury. However, our understanding of what drives this dysfunction is limited. Genetic variation among individuals within a population gives rise to single nucleotide polymorphisms (SNPs) that have the potential to influence a given patient’s cerebrovascular response to an injury. Associations have been reported between a variety of genetic polymorphisms and global outcome in patients with TBI, but few studies have explored the association between genetics and cerebrovascular function after injury. In this Review, we explore polymorphisms that might play an important part in cerebral autoregulatory capacity after TBI. We outline a variety of SNPs, their biological substrates and their potential role in mediating cerebrovascular reactivity. A number of candidate polymorphisms exist in genes that are involved in myogenic, endothelial, metabolic and neurogenic vascular responses to injury. Furthermore, polymorphisms in genes involved in inflammation, the central autonomic response and spreading cortical depression might drive cerebrovascular reactivity. Identification of candidate genes involved in cerebral autoregulation after TBI provides a platform and rationale for further prospective investigation of the link between genetic polymorphisms and autoregulatory function